Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Mexico - Delayed Quote MXN

RECURSION PHARMACEUTICALS INC (RXRX.MX)

124.00
0.00
(0.00%)
As of March 11 at 11:00:43 AM CST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
58,488
58,488
43,876
39,681
10,000
Cost of Revenue
45,238
45,238
42,587
48,275
--
Gross Profit
13,250
13,250
1,289
-8,594
10,000
Operating Expense
492,254
492,254
351,349
237,133
192,775
Operating Income
-479,004
-479,004
-350,060
-245,727
-182,775
Net Non Operating Interest Income Expense
14,186
14,186
19,019
6,199
-2,879
Other Income Expense
30
30
-1,087
52
-825
Pretax Income
-464,788
-464,788
-332,128
-239,476
-186,479
Tax Provision
-1,127
-1,127
-4,062
--
--
Net Income Common Stockholders
-463,661
-463,661
-328,066
-239,476
-186,479
Diluted NI Available to Com Stockholders
-463,661
-463,661
-328,066
-239,476
-186,479
Basic EPS
-1.54
--
-1.58
-1.36
-1.49
Diluted EPS
-1.54
--
-1.58
-1.36
-1.49
Basic Average Shares
245,621.05
--
207,853.70
175,537.49
125,348.11
Diluted Average Shares
245,621.05
--
207,853.70
175,537.49
125,348.11
Total Operating Income as Reported
-479,004
-479,004
-350,060
-245,727
-182,775
Total Expenses
537,492
537,492
393,936
285,408
192,775
Net Income from Continuing & Discontinued Operation
-463,661
-463,661
-328,066
-239,476
-186,479
Normalized Income
-463,661
-463,661
-328,066
-239,476
-185,652
Interest Income
15,758
15,758
19,116
6,254
73
Interest Expense
1,572
1,572
97
55
2,952
Net Interest Income
14,186
14,186
19,019
6,199
-2,879
EBIT
-463,216
-463,216
-332,031
-239,421
-183,527
EBITDA
-426,722
-426,722
-307,629
-227,665
-175,122
Reconciled Cost of Revenue
45,238
45,238
42,587
48,275
--
Reconciled Depreciation
36,494
36,494
24,402
11,756
8,405
Net Income from Continuing Operation Net Minority Interest
-463,661
-463,661
-328,066
-239,476
-186,479
Total Unusual Items Excluding Goodwill
--
--
--
--
-827
Total Unusual Items
--
--
--
--
-827
Normalized EBITDA
-426,722
-426,722
-307,629
-227,665
-174,295
Tax Rate for Calcs
0
0
0
--
--
12/31/2021 - 2/14/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

8QQ.SG AbCellera Biologics Inc
2.2400
-0.04%
 
OBSEF ObsEva SA
0.0001
0.00%
 
RCKTW Rocket Pharmaceuticals, Inc.
0.0850
+70.00%
 
SCNI Scinai Immunotherapeutics Ltd.
2.5100
+0.80%
 
BION.SW BB Biotech AG Ord
28.25
-0.70%
 
ELVN Enliven Therapeutics, Inc.
17.82
+0.25%
 
IDIA.SW Idorsia Ltd
1.1460
-1.04%
 
ENVB Enveric Biosciences, Inc.
1.3600
+5.43%
 
CYBN.NE Cybin Inc.
9.80
+2.60%
 
PEPG PepGen Inc.
1.6200
+0.62%